The Role of Mineralocorticoids in Open Angle Glaucoma
Author Information
Author(s): Christian Albrecht May
Primary Institution: Department of Anatomy, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany
Hypothesis
Can mineralocorticoids play a role in the pathophysiology of open angle glaucoma?
Conclusion
Mineralocorticoids may have a limited role in the development of glaucoma, but further specific experiments are needed to draw definitive conclusions.
Supporting Evidence
- Mineralocorticoids are known to lower intraocular pressure.
- Previous studies have shown that aldosterone-antagonist spironolactone decreased intraocular pressure in glaucomatous patients.
- Systemic application of mineralocorticoids shows no changes in intraocular pressure in most cases.
Takeaway
This study looks at how certain hormones might affect eye pressure and glaucoma, but it finds that we still need more research to understand their role.
Methodology
The study involved a review of existing literature and personal investigations regarding the effects of mineralocorticoids on intraocular pressure.
Limitations
The study lacks specific experimental data on the role of mineralocorticoids in glaucoma pathophysiology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website